James Davies
DPhil, MRCP
Professor of Genomics
- Honorary Consultant Haematologist
Biography
I am a clinician scientist with a specialist interest in haematopoietic stem cell transplantation, genome editing, functional genomics and bioinformatics. My research group is based at the MRC Weatherall Institute of Molecular Medicine, University of Oxford, and I am an Honorary Consultant Haematologist with the Oxford allogeneic bone marrow transplant service.
Our research seeks to understand the fundamental mechanisms that control gene regulation. We have a particular interest in developing technologies that reveal the three-dimensional structure of the genome at unprecedented resolution, enabling us to determine how the physical organisation of DNA regulates gene expression in normal cells and how these processes are disrupted in cancer and other diseases.
By combining genomics, genome engineering and computational biology, we investigate how genetic variation alters gene regulation and contributes to disease risk. We use these insights to identify new therapeutic targets and develop genome editing strategies for blood and bone marrow-derived cells, with the long-term goal of translating fundamental discoveries into new treatments for patients.
Key publications
Mapping chromatin structure at base-pair resolution unveils a unified model of cis-regulatory element interactions
Journal article
Li H. et al, (2025), Cell, 188, 7175 - 7193.e19
Analysis of sub-kilobase chromatin topology reveals nano-scale regulatory interactions with variable dependence on cohesin and CTCF
Journal article
Aljahani A. et al, (2022), Nature Communications, 13
Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus
Journal article
Downes DJ. et al, (2021), Nature Genetics, 53, 1606 - 1615
Defining genome architecture at base-pair resolution
Journal article
Hua P. et al, (2021), Nature, 595, 125 - 129
Recent publications
Context-specific regulatory genetic variation in MTOR dampens neutrophil-T cell crosstalk in pneumonia-associated sepsis
Journal article
Zhang P. et al, (2026), Nature Communications, 17
MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia
Journal article
Lau IJ. et al, (2026), Blood
ORCID
0000-0002-4108-4357
